These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 7669728)

  • 1. Transfection of TRK-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor.
    Lavenius E; Gestblom C; Johansson I; Nånberg E; Påhlman S
    Cell Growth Differ; 1995 Jun; 6(6):727-36. PubMed ID: 7669728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and function of the nerve growth factor receptor (TRK-A) in human neuroblastoma cell lines.
    Azar CG; Scavarda NJ; Nakagawara A; Brodeur GM
    Prog Clin Biol Res; 1994; 385():169-75. PubMed ID: 7972209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of NGF responsiveness in human neuroblastoma.
    Bogenmann E; Peterson S; Maekawa K; Matsushima H
    Oncogene; 1998 Nov; 17(18):2367-76. PubMed ID: 9811468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NGF induces terminal differentiation in trkA expressing neuroblastoma cells in vitro and in vivo.
    Matsushima H; Bogenmann E
    Prog Clin Biol Res; 1994; 385():177-83. PubMed ID: 7972210
    [No Abstract]   [Full Text] [Related]  

  • 5. The trk family of oncogenes and neurotrophin receptors.
    Lamballe F; Klein R; Barbacid M
    Princess Takamatsu Symp; 1991; 22():153-70. PubMed ID: 1844238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of nerve growth factor responsiveness in C6-2B glioma cells by expression of trkA proto-oncogene.
    Colangelo AM; Fink DW; Rabin SJ; Mocchetti I
    Glia; 1994 Oct; 12(2):117-27. PubMed ID: 7868185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in early and late responses between neurotrophin-stimulated trkA- and trkC-transfected SH-SY5Y neuroblastoma cells.
    Edsjö A; Hallberg B; Fagerström S; Larsson C; Axelson H; Påhlman S
    Cell Growth Differ; 2001 Jan; 12(1):39-50. PubMed ID: 11205744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
    Albor A; Thraves PJ; Dritschilo A; Notario V
    Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TrkA neurogenic receptor regulates differentiation of neuroblastoma cells.
    Poluha W; Poluha DK; Ross AH
    Oncogene; 1995 Jan; 10(1):185-9. PubMed ID: 7824271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P53 associates with trk tyrosine kinase.
    Montano X
    Oncogene; 1997 Jul; 15(3):245-56. PubMed ID: 9233759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive N-myc gene expression inhibits trkA mediated neuronal differentiation.
    Bogenmann E; Torres M; Matsushima H
    Oncogene; 1995 May; 10(10):1915-25. PubMed ID: 7761093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of human p140trk receptors in p140trk-deficient, PC12/endothelial cells results in nerve growth factor-induced signal transduction and DNA synthesis.
    Jiang H; Movsesyan V; Fink DW; Fasler M; Whalin M; Katagiri Y; Monshipouri M; Dickens G; Lelkes PI; Guroff G; Lazarovici P
    J Cell Biochem; 1997 Aug; 66(2):229-44. PubMed ID: 9213224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling.
    Oelmann E; Sreter L; Schuller I; Serve H; Koenigsmann M; Wiedenmann B; Oberberg D; Reufi B; Thiel E; Berdel WE
    Cancer Res; 1995 May; 55(10):2212-9. PubMed ID: 7538048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nerve growth factor-induced differentiation of human neuroblastoma and neuroepithelioma cell lines.
    Chen J; Chattopadhyay B; Venkatakrishnan G; Ross AH
    Cell Growth Differ; 1990 Feb; 1(2):79-85. PubMed ID: 1964795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terminal differentiation in neuroblastoma cells transfected with the NGF receptor gene when treated with NGF.
    Matsushima H; Bogenmann E
    Prog Clin Biol Res; 1991; 366():227-33. PubMed ID: 1648742
    [No Abstract]   [Full Text] [Related]  

  • 16. Nerve growth factor-induced differentiation in PC-12 cells is blocked by fos oncogene.
    Ito E; Sonnenberg JL; Narayanan R
    Oncogene; 1989 Oct; 4(10):1193-9. PubMed ID: 2552373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cotransfection of TrkA and p75(NTR) in neuroblastoma cell line (IMR-32) promotes differentiation and apoptosis of tumor cells.
    Chen J; Zhe X
    Chin Med J (Engl); 2003 Jun; 116(6):906-12. PubMed ID: 12877805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unliganded c-erbA/thyroid hormone receptor induces trkB expression in neuroblastoma cells.
    Pastor R; Bernal J; Rodríguez-Peña A
    Oncogene; 1994 Apr; 9(4):1081-9. PubMed ID: 8134111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis.
    Kogner P; Barbany G; Dominici C; Castello MA; Raschellá G; Persson H
    Cancer Res; 1993 May; 53(9):2044-50. PubMed ID: 8481906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of TRK-T1 oncogene induces differentiation of PC12 cells.
    Greco A; Orlandi R; Mariani C; Miranda C; Borrello MG; Cattaneo A; Pagliardini S; Pierotti MA
    Cell Growth Differ; 1993 Jul; 4(7):539-46. PubMed ID: 8398895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.